REEP1
Receptor expression-enhancing protein 1
Also known as: C2orf23, FLJ13110, REEP1_HUMAN, SPG31, Yip2a
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H902
- Gene
- REEP1
- Ensembl
- ENSG00000068615
- Chromosome
- 2
- Canonical length
- 201 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a mitochondrial protein that functions to enhance the cell surface expression of odorant receptors. Mutations in this gene cause spastic paraplegia autosomal dominant type 31, a neurodegenerative disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>Q9H902|REEP1
1 MVSWIISRLV VLIFGTLYPA YYSYKAVKSK DIKEYVKWMM YWIIFALFTT AETFTDIFLC
61 WFPFYYELKI AFVAWLLSPY TKGSSLLYRK FVHPTLSSKE KEIDDCLVQA KDRSYDALVH
121 FGKRGLNVAA TAAVMAASKG QGALSERLRS FSMQDLTTIR GDGAPAPSGP PPPGSGRASG
181 KHGQPKMSRS ASESASSSGT ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against REEP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- testis: 42 nTPM
- colon: 37 nTPM
- hypothalamus: 32 nTPM
- cerebral cortex: 29 nTPM
- basal ganglia: 25 nTPM
- blood vessel: 21 nTPM
Single-cell type
- sertoli cells: 739 nCPM
- myonuclei: 202 nCPM
- lactotrophs: 178 nCPM
- other brain neurons: 158 nCPM
- brain inhibitory neurons: 137 nCPM
- retinal ganglion cells: 124 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 131 nTPM
- hypothalamus: 119 nTPM
- midbrain: 106 nTPM
- cerebral cortex: 88 nTPM
- medulla oblongata: 76 nTPM
- thalamus: 64 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about REEP1.
Disease | AllUniProt
Conditions REEP1 is implicated in, by any mechanism.
- Spastic paraplegia 31, autosomal dominant (SPG31) MIM:610250
- Neuronopathy, distal hereditary motor, autosomal dominant 12 (HMND12) MIM:614751
- Neuronopathy, distal hereditary motor, autosomal recessive 6 (HMNR6) MIM:620011
Disease | GeneticClinVar
90 pathogenic / likely-pathogenic of 461 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary spastic paraplegia 31
- Hereditary spastic paraplegia
- Neuronopathy, distal hereditary motor, type 5B
- Inborn genetic diseases
- Spinal muscular atrophy, distal, autosomal recessive, 6
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.35
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of REEP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads REEP1 as an antibody target. Whether an autoantibody or antibody against REEP1 could matter depends on whether native REEP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
REEP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label REEP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...